HPV vaccine uptake among overweight and obese US adolescents: An analysis of the National Health and Nutrition Examination Survey (NHANES) 2009–2014

Sundaram, Maria E.; Mason, Susan M.; Basta, Nicole E.

doi:10.1016/j.vaccine.2016.03.064

Cited by 5 publications

(2 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…One large study identified disrespectful treatment, embarrassment with being weighed, negative attitudes of providers, unsolicited weight loss advice, and poorly fit equipment and facilities as reasons why women with obesity were more likely to delay screening for breast and cervical cancer (Amy, Aalborg, Lyons, & Keranen, 2006). Previous studies have noted mixed findings when assessing disparities by body weight in receipt of HPV, pneumococcus, or influenza vaccinations, but no HPV vaccination studies have included adolescent and adult women in a large, nationally representative sample or controlled for known confounders such as differences in healthcare utilization (Harper et al, 2014; Harris, Moniz, Iott, Power, & Griggs, 2016; Sundaram, Mason, & Basta, 2016).…”

Section: Introductionmentioning

confidence: 99%

Obesity and Disparities in Human Papillomavirus Vaccination for U.S. Adolescent Girls and Young Women

Harris

Garrett

Akers

2019

Women's Health Issues

View full text Add to dashboard Cite

Background: Obesity is recognized as a barrier to receiving women’s preventive health services, including cervical and breast cancer screening. Little is known about whether obesity is associated with a lower incidence of human papillomavirus (HPV) vaccination, another important preventive care service for adolescent girls and young women. The objective of this study was to determine if adolescent girls and young women with obesity are less likely to receive HPV vaccination compared to individuals with normal weight. Methods: We examined whether HPV vaccination was associated with obesity status in women aged 9 to 30 years surveyed from 2009 to 2016 by the U.S. National Health and Nutrition Examination Study. Results from logistic and linear regression models were adjusted for age, race, income, insurance status, self-reported health, and health care utilization, accounting for the weighted survey design. Results: The final cohort included 5,517 women. 32.9% of participants reported vaccination, with a mean age at vaccination of 15.8 years. Adolescent girls and young women with obesity were less likely to report vaccination; the adjusted odds ratio of vaccination was 0.79 (p=0.01) compared to normal weight women. Among those vaccinated, the age at vaccination was significantly higher for women with obesity, 16.3 years compared to 15.2 years (p=0.002), but there was no difference in the completion of the vaccination series rate by obesity. Conclusions: Adolescent girls and young women with obesity were less likely to report HPV vaccination and, if they were vaccinated, received the vaccination at a later age.

show abstract

Section: Introductionmentioning

confidence: 99%

Obesity and Disparities in Human Papillomavirus Vaccination for U.S. Adolescent Girls and Young Women

Harris

Garrett

Akers

2019

Women's Health Issues

View full text Add to dashboard Cite

show abstract

“…Based on the factors associated with HPV-infection that are reported in the previous study [32][33][34][35][36][37][38][39][40][41][42][43], we use these factors as the covariates. So these covariates involved in this analysis consist of vitamin K intake data, sociodemographic data, experimental data, questionnaire data, and data from a physical examination.…”

Section: Variables In the Analysismentioning

confidence: 99%

Dietary Vitamin K Intake and HPV-Infection Status Among American Women: A Secondary Analysis From National Health and Nutrition Examination Survey Data From 2003 to 2016

Jiang

Xu²,

Lan³

et al. 2022

Int J Public Health

View full text Add to dashboard Cite

Objective: Cervical cancer is a serious potential risk to women’s health, and is closely related to persistent HPV infection. Vitamin K mainly existed in green vegetables, fruit, and dairy products. This research aims to observe the association between vitamin K and HPV-infection.Methods: 13,447 participants from the NHANES were selected. Dietary vitamin K intake was used as the objective independent variable and continuous variable, HPV-infection status was used as the outcome variable, and characteristics of selected participants were used as the covariates.Results: There was a nonlinearity between vitamin K intake and HPV-infection, and the inflection point is 3.81 of log2 vitamin K intake. In a range of 0–3.81, Each one-unit increase in log2 vitamin K intake was associated with a 43% reduction in the risk of HPV infection. When log2 vitamin K intake excess of 3.81, the risk of HPV infection did not continue to decline. The HPV-subtype was not associated with vitamin K intake.Conclusion: There is a nonlinearity between vitamin K intake and HPV-infection status. But HPV-subtype was not associated with vitamin K intake.

show abstract

HPV Vaccination and the Risk of Invasive Cervical Cancer

Lei¹,

Ploner²,

et al. 2020

View full text Add to dashboard Cite

HPV vaccine uptake among overweight and obese US adolescents: An analysis of the National Health and Nutrition Examination Survey (NHANES) 2009–2014

Cited by 5 publications

References 28 publications

Obesity and Disparities in Human Papillomavirus Vaccination for U.S. Adolescent Girls and Young Women

Obesity and Disparities in Human Papillomavirus Vaccination for U.S. Adolescent Girls and Young Women

Dietary Vitamin K Intake and HPV-Infection Status Among American Women: A Secondary Analysis From National Health and Nutrition Examination Survey Data From 2003 to 2016

HPV Vaccination and the Risk of Invasive Cervical Cancer

Contact Info

Product

Resources

About